Saccharomyces cerevisiae and Improved Effectiveness in Inflammatory Bowel Disease

• Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches.

  • 2023-09-26
  • Review
  • Microbiome research reports 2(4)
  • • Catherine O'Reilly
    • Susan Mills
    • Mary C Rea
    • Aonghus Lavelle
    • Subrata Ghosh
    • Colin Hill
    • R Paul Ross

  • PubMed: 37849974
  • DOI: 10.20517/mrr.2023.41

  3 Insights on

  • Improved Effectiveness in Inflammatory Bowel Disease

  • Low evidence

  preclinical studies have revealed that such alterations can play an important role in therapeutic efficacy

  Effect

  Beneficial

  Effect size

  Moderate